Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II

被引:27
作者
Da Silva, G.
Dijkshoorn, L.
van der Reijden, T.
van Strijen, B.
Duarte, A.
机构
[1] Univ Coimbra, Microbiol Lab, Fac Pharm, P-3000432 Coimbra, Portugal
[2] Univ Coimbra, Ctr Pharmaceut Studies, P-3000432 Coimbra, Portugal
[3] Leiden Univ, Ctr Med, Dept Infect Dis, Leiden, Netherlands
[4] Univ Lisbon, Microbiol Lab, Fac Pharm, P-1699 Lisbon, Portugal
关键词
Acinetobacter baumannii; AFLP analysis; epidemiology; multidrug resistance; nosocomial infection; typing;
D O I
10.1111/j.1469-0691.2006.01628.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aims of this study were to determine whether a multidrug-resistant Acinetobacter baumannii clone, known to be endemic in three tertiary-care Portuguese hospitals, had disseminated throughout Portugal, and whether this clone was related to one of the European clones I-III described previously. The isolates were first screened by pulsed-field gel electrophoresis and/or M13 random amplified polymorphic DNA fingerprint analysis. Ten representative isolates were compared by amplified fragment length polymorphism (AFLP) analysis, and were also compared with isolates contained in the AFLP library of the Leiden University Medical Centre. All of the Portuguese isolates clustered in European clone II (clone delineation level > 80%). Following AFLP analysis, seven isolates clustered at > 96%, indicating a striking degree of genetic relatedness and suggesting recent spread of a (sub)clone. Three isolates were slightly more separated from this main group, but all isolates clustered at 87.4%. Thus, the Portuguese multidrug-resistant isolates formed a sub-cluster of European clone II, suggesting that they belong to a recent lineage within clone II.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 19 条
[1]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[2]   PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii [J].
Bou, G ;
Cerveró, G ;
Domínguez, MA ;
Quereda, C ;
Martínez-Beltrán, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (12) :635-643
[3]   Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Montero, A ;
Pujol, M ;
Domínguez, MA ;
Ayats, J ;
Argerich, MJ ;
Garrigosa, F ;
Ariza, J ;
Gudiol, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4086-4095
[4]   Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula [J].
Da Silva, GJ ;
Quinteira, S ;
Bértolo, E ;
Sousa, JC ;
Gallego, L ;
Duarte, A ;
Peixe, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :255-258
[5]   Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods [J].
Dijkshoorn, L ;
Aucken, H ;
GernerSmidt, P ;
Janssen, P ;
Kaufmann, ME ;
Garaizar, J ;
Ursing, J ;
Pitt, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1519-1525
[6]   Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species [J].
Dijkshoorn, L ;
van Harsselaar, B ;
Tjernberg, I ;
Bouvet, PJM ;
Vaneechoutte, M .
SYSTEMATIC AND APPLIED MICROBIOLOGY, 1998, 21 (01) :33-39
[7]   Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. [J].
Grundmann, HJ ;
Towner, KJ ;
Dijkshoorn, L ;
GernerSmidt, P ;
Maher, M ;
Seifert, H ;
Vaneechoutte, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3071-3077
[8]   Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York:: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage [J].
Manikal, VM ;
Landman, D ;
Saurina, G ;
Oydna, E ;
Lal, H ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) :101-106
[9]  
Maslow Joel N., 1993, P563
[10]  
*NAT COMM CLIN LAB, 2000, M100S9 NCCLS S